Allurion to Report First Quarter 2025 Financial Results on May 14, 2025. NATICK, Mass., May 05, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ...

NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), known for its efforts in combating obesity and maintaining impressive gross profit margins of 73%, disclosed today its plan to conduct a ...

The patent, dated January 15, 2025, is expected to protect the company's technology through July 2039. With this development, Allurion's U.S. patent count rises to 20, complementing its global ...

Allurion Technologies Inc. (NYSE:ALUR) is developing a weight loss program, Allurion Program, that includes a swallowable gastric balloon and a monitoring program that reduce body fat as the ...

Allurion Technologies, Inc. (“Allurion”), a company dedicated to ending obesity, and Compute Health Acquisition Corp, a special purpose acquisition co.

View Allurion Technologies, Inc. ALUR stock quote prices, financial information, real-time forecasts, and company news from CNN.

View Allurion Technologies, Inc. ALUR stock quote prices, financial information, real-time forecasts, and company news from CNN.

Allurion Technologies Inc. (NYSE:ALUR) Q4 2024 Earnings Conference Call March 26, 2025 8:30 AM ETCompany Participants. Mike Cavanaugh - Investor Relations Shantanu Gaur - Founder and Chief ...

Allurion Technologies ALUR shares are moving higher Friday, potentially in response to the company's Thursday announcement of a planned clinical study to evaluate the combination of its Allurion ...

Shares of Allurion Technologies rallied after the company said patients lost weight and maintained muscle mass while using its Allurion Balloon and AI-Powered Virtual Care Suite. The stock rose 42 ...